Insider Trading History of Attar Eyal C.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Attar Eyal C. since year 2005. The trader's CIK number is 1789076. At the time of the last reporting, Attar Eyal C. was the SVP, Chief Medical Officer of Aprea Therapeutics, Inc. . (stock ticker symbol APRE). See this page for all insider trading activities at Aprea Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Attar Eyal C. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-10-07 APRE Aprea Therapeutics, Inc. Buy 400 15.00 6,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Attar Eyal C. (SVP, Chief Medical Officer of Aprea Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month